Evercore ISI's Schoenebaum Breaks Down Celgene-Receptos Merger

By: via Benzinga
In a new presentation, Evercore ISI analyst Mark Schoenebaum breaks down the recently announced Celgene Corporation (NASDAQ: CELG) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.